
Figure 1
Flowchart of study participants.
Table 1
The variable assignment.
| VARIABLE | THE ASSIGNMENT |
|---|---|
| Sex | 1 = male; 2 = female |
| Age | 68 ± 10 |
| BMI (kg/m2) | 24 ± 3 |
| HR (times/min) | 74 ± 11 |
| Blood glucose(mmol/L) | 5.9 ± 1.9 |
| Educational status | 1 = primary, 2 = middle, 3 = high, 4 = college, 5 = master |
| Smoking | 0 = never, 1 = current, 2 = past, 3 = don’t smoke but has a long history of secondhand smoke inhalation |
| Drinking | 0 = never,1 = current, 2 = past |
| Outdoor activities (hours/week) | 1 =≥ 20, 2 = 5–20, 3 =≤ 5 |
| Vegetable consumption (days/week) | 1 =≥ 5, 2 = 3–5, 3 =≤ 3 |
| Fruit consumption (day/week) | 1 =< 3, 2 =≥ 3 |
| Sleep duration (hours/days) | 1 = 6–8, 2 =< 6, 3 => 8 |
| Hypertension | 0 = no, 1 = yes |
| Diabetes | 0 = no, 1 = yes |
| Hyperlipidemia | 0 = no, 1 = yes |
| Hyperhomocysteinemia | 0 = no, 1 = yes |
| CVD | 0 = no, 1 = yes |
| CHF | 0 = no, 1 = yes |
| CRF | 0 = no, 1 = yes |
| AF | 0 = no, 1 = yes |
| Cerebral infarction | 0 = no, 1 = yes |
| Cerebral hemorrhage | 0 = no, 1 = yes |
| Use of antihypertensives | 0 = no, 1 = yes |
| Use of lipid-lowering agents | 0 = no, 1 = yes |
[i] BMI: body mass index. HR: heart rate. CVD: coronary vessel disease. CHF: chronic hepatic failure. CRF: chronic renal failure. AF: atrial fibrillation.
Table 2
Baseline characteristics of all participants by hypertension status.
| VARIABLE | HYPERTENSION | P | |
|---|---|---|---|
| YES | NO | ||
| Sex(%) | 0.378 | ||
| male | 4,533(44.2) | 4,265(43.6) | |
| female | 5,728(55.8) | 5,527(56.4) | |
| Age | 71 ± 8 | 66 ± 11 | <0.01 |
| BMI | 25 ± 3 | 24 ± 3 | <0.01 |
| HR | 74 ± 11 | 73 ± 11 | <0.01 |
| Blood glucose | 6.0 ± 2.0 | 5.9 ± 1.8 | 0.002 |
| Educational status(%) | <0.01 | ||
| primary | 7,611(74.2) | 6,713(68.6) | |
| middle | 1,817(17.7) | 1,915(19.6) | |
| high | 650(6.3) | 733(7.5) | |
| college | 182(1.8) | 429(4.4) | |
| master | 1(0.0) | 2(0.0) | |
| Smoking(%) | 0.007 | ||
| never | 8,020(78.2) | 7,531(76.9) | |
| current | 1,425(13.9) | 1,464(15.0) | |
| past | 198(1.9) | 150(1.5) | |
| long history of second-hand smoke inhalation | 618(6.0) | 647(6.6) | |
| Drinking(%) | 0.428 | ||
| never | 8,504(82.9) | 8,047(82.2) | |
| current | 1,630(15.9) | 1,617(16.5) | |
| past | 127(1.2) | 128(1.3) | |
| Outdoor activities(%) | <0.01 | ||
| ≥20 | 4,681(45.6) | 3,854(39.4) | |
| 5–20 | 4,379(42.7) | 4,560(46.6) | |
| ≤5 | 1,201(11.7) | 1,378(14.1) | |
| Vegetable consumption(%) | <0.01 | ||
| ≥5 | 7,433(72.4) | 6,681(68.2) | |
| 3–5 | 2,226(21.7) | 2,545(26.0) | |
| ≤3 | 602(5.9) | 566(5.8) | |
| Fruit consumption(%) | 0.017 | ||
| ≥3 | 4,005(39.0) | 3,985(40.7) | |
| <3 | 6,256(61.0) | 5,807(59.3) | |
| Sleep duration(%) | <0.01 | ||
| 6–8 | 7,593(74.0) | 7,567(77.3) | |
| <6 | 1,982(19.3) | 1,534(15.7) | |
| >8 | 686(6.7) | 691(7.1) | |
| Diabetes(%) | <0.01 | ||
| yes | 1,894(18.5) | 1,230(12.6) | |
| no | 8,367(81.5) | 8,562(87.4) | |
| Hyperlipidemia(%) | <0.01 | ||
| yes | 2,065(20.1) | 1,426(14.6) | |
| no | 8,196(79.9) | 8,366(85.4) | |
| Hyperhomocysteinemia(%) | <0.01 | ||
| yes | 52(0.5) | 5(0.1) | |
| no | 10,209(99.5) | 9,787(99.9) | |
| CVD(%) | <0.01 | ||
| yes | 604(5.9) | 224(2.3) | |
| no | 9,657(94.1) | 9,568(97.7) | |
| CHF(%) | 0.093 | ||
| yes | 120(1.2) | 141(1.4) | |
| no | 10,141(98.8) | 9,651(98.6) | |
| CRF(%) | 0.001 | ||
| yes | 36(0.4) | 12(0.1) | |
| no | 10,225(99.6) | 9,780(99.9) | |
| AF(%) | 0.008 | ||
| yes | 51(0.5) | 26(0.3) | |
| no | 10,210(99.5) | 9,766(99.7) | |
| Cerebral infarction(%) | 0.001 | ||
| yes | 173(1.7) | 110(1.1) | |
| no | 10,088(98.3) | 9,682(98.9) | |
| Cerebral hemorrhage(%) | <0.01 | ||
| yes | 50(0.5) | 11(0.1) | |
| no | 10,211(99.5) | 9,781(99.9) | |
| Use of antihypertensives(%) | <0.01 | ||
| yes | 7,578(73.9) | 0(0.0) | |
| no | 2,683(26.1) | 9,792(100.0) | |
| Use of lipid-lowering agents(%) | <0.01 | ||
| Yes | 434(4.2) | 182(1.9) | |
| no | 9,827(95.8) | 9,610(98.1) | |
[i] A P < 0.05 was considered significant. BMI: body mass index. HR: heart rate. CVD: coronary vessel disease. CHF: chronic hepatic failure. CRF: chronic renal failure. AF: atrial fibrillation.
Table 3
Unadjusted analysis between sleep duration and hypertension.
| SLEEP DURATION | TOTAL | HYPERTENSION (%) | χ2 TEST | LOGISTIC REGRESSION ANALYSIS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NO | YES | χ2 | P | OR | P | 95%CI | |||||
| Normal (6–8h/day) | 15,160 | 7,567 (49.9) | 7,593 (50.1) | 46.2 | <0.01 | * | |||||
| Short (<6h/day) | 3,516 | 1,534 (43.6) | 1,982 (56.4) | # | 1.011 | 0.849 | 0.905–1.129 | ||||
| Long (>8h/day) | 1,377 | 691 (50.2) | 686(49.8) | 1.301 | <0.010 | 1.149–1.475 | |||||
[i] * Compared with normal (6–8 h/day) and long (>8 h/day), it was statistically significant.

Figure 2
To evaluate the association between sleep duration and hypertension by four multivariate logistic regression models.
